Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | MALT1 | Q9UDY8 | 1/20 | 0.32 |
| ▸ | DHODH | Q02127 | 2/20 | 0.31 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | ELANE | P08246 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL950843 | 0.91 | — | — | |
| SCHEMBL29215020 | 0.90 | MAPT (0.31) | MAPTDHODHCYP17A1CYP1A2 | |
| SCHEMBL1762497 | 0.90 | MAPT (0.33) | MAPTDHODHCYP17A1CYP1A2ELANE | |
| SCHEMBL30234030 | 0.89 | MAPT (0.31) | MAPT | |
| SCHEMBL29215194 | 0.87 | — | — | |
| SCHEMBL499517 | 0.87 | KDM4E (0.34) | MAPTDHODHCYP17A1CYP1A2ALDH1A1 | |
| SCHEMBL28507071 | 0.87 | ALDH1A1 (0.31) | MAPTDHODHCYP17A1CYP1A2ALDH1A1 | |
| SCHEMBL950938 | 0.86 | CYP17A1 (0.34) | MAPTMALT1DHODHCYP17A1CYP1A2 | |
| SCHEMBL1762432 | 0.86 | CYP17A1 (0.34) | MAPTMALT1DHODHCYP17A1CYP1A2 | |
| SCHEMBL25275332 | 0.85 | MAPT (0.39) | MAPTDHODHELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8697734-B2 | Method for controlling particular insect pests by applying anthranilamide compounds | E I DU PONT DE NEMOURS AND COMPANY (US) | 2014-04-15 | — | — | US | disclosed |
| US-20130028879-A1 | METHOD FOR CONTROLLING PARTICULAR INSECT PESTS BY APPLYING ANTHRANILAMIDE COMPOUNDS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130028879-A1 | METHOD FOR CONTROLLING PARTICULAR INSECT PESTS BY APPLYING ANTHRANILAMIDE COMPOUNDS | ANTXR2, CYP4X1, PRDX1 | MAPT 4861/4885MALT1 2245/4885DHODH 1151/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.